4.7 Article

Cognitive subtypes of probable Alzheimer's disease robustly identified in four cohorts

期刊

ALZHEIMERS & DEMENTIA
卷 13, 期 11, 页码 1226-1236

出版社

WILEY
DOI: 10.1016/j.jalz.2017.03.002

关键词

Alzheimer's disease; Cognition; Heterogeneity; Subtypes; Atypical; Neuropsychology

资金

  1. Alzheimer Nederland
  2. Stichting VUmc Fonds
  3. Stichting Dioraphte
  4. Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]
  5. DOD ADNI (Department of Defense) [W81XWH-12-2-0012]
  6. National Institute on Aging
  7. National Institute of Biomedical Imaging and Bioengineering
  8. AbbVie
  9. Alzheimer's Association
  10. Alzheimer's Drug Discovery Foundation
  11. Araclon Biotech
  12. BioClinica, Inc
  13. Biogen
  14. Bristol-Myers Squibb Company
  15. CereSpir, Inc
  16. Cogstate
  17. Eisai Inc
  18. Elan Pharmaceuticals, Inc
  19. Eli Lilly and Company
  20. EuroImmun
  21. F. Hoffmann-La Roche Ltd
  22. company Genentech, Inc
  23. Fujirebio
  24. GE Healthcare
  25. IXICO Ltd
  26. Janssen Alzheimer Immunotherapy Research & Development, LLC
  27. Johnson & Johnson Pharmaceutical Research & Development LLC
  28. Lumosity
  29. Lundbeck
  30. Merck Co, Inc
  31. Meso ScaleDiagnostics, LLC
  32. NeuroRx Research
  33. Neurotrack Technologies
  34. Novartis Pharmaceuticals Corporation
  35. Pfizer Inc
  36. Piramal Imaging
  37. Servier
  38. Takeda Pharmaceutical Company
  39. Transition Therapeutics
  40. Canadian Institutes of Health Research
  41. German Federal Ministry of Education and Research (BMBF) [01GI0420]

向作者/读者索取更多资源

Introduction: Patients with Alzheimer's disease (AD) show heterogeneity in profile of cognitive impairment. We aimed to identify cognitive subtypes in four large AD cohorts using a data-driven clustering approach. Methods: We included probable AD dementia patients from the Amsterdam Dementia Cohort (n = 496), Alzheimer's Disease Neuroimaging Initiative (n = 376), German Dementia Competence Network (n = 521), and University of California, San Francisco (n = 589). Neuropsychological data were clustered using nonnegative matrix factorization. We explored clinical and neurobiological characteristics of identified clusters. Results: In each cohort, a two-clusters solution best fitted the data (cophenetic correlation > 0.9): one cluster was memory-impaired and the other relatively memory spared. Pooled analyses showed that the memory-spared clusters (29%-52% of patients) were younger, more often apolipoprotein E (APOE) epsilon 4 negative, and had more severe posterior atrophy compared with the memory-impaired clusters (all P < .05). Conclusions: We could identify two robust cognitive clusters in four independent large cohorts with distinct clinical characteristics. (C) 2017 the Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据